Quantum announces co-proxamol shortage
October 19 2015
Quantum Pharmaceutical has announced that co-proxamol 325mg/32.5mg tablets are now subject to a manufacturer quota, due to a shortage in the market.
“Our primary aim is to ensure minimum disruption to our service to customers and of course continuous supply of product for the end patient,” said the company last week. “Whilst stock of this product continues to be in short supply, some pharmacies may need to refer the scripts back to prescriber to seek a suitable alternative until the product is readily available in the market.”
Quantum, a manufacturer and supplier of unlicensed ‘specials’ medicines, said that it would keep customers updated about stock availability at the point of order.